(81 days)
Not Found
No
The description focuses on standard hematology analysis methods (DC detection, flow cytometry, SLS-hemoglobin method) and hardware/software modifications for sample handling and stability. There is no mention of AI or ML algorithms for data analysis, interpretation, or decision-making.
No
Explanation: The device is an automated hematology analyzer used for in vitro diagnostic testing, which means it analyzes blood samples to provide diagnostic information, not to treat patients.
Yes
The device is described as an "automated hematology analyzer for in vitro diagnostic use." It performs tests on blood samples to provide various parameters (e.g., WBC, RBC, HGB), which are used to diagnose and monitor medical conditions.
No
The device description explicitly states it is a multi-parameter hematology analyzer consisting of a Main Unit (hardware for aspirating, diluting, mixing, and analyzing blood), an Auto Loader (hardware for sample supply), and an IPU (Information Processing Unit, which includes software but is part of a larger hardware system). It also mentions hardware modifications as part of the described change.
Yes, this device is an IVD (In Vitro Diagnostic).
The "Intended Use / Indications for Use" section explicitly states: "The Sysmex® XS-1000iC is an automated hematology analyzer for in vitro diagnostic use in clinical laboratories and reference laboratories."
This statement directly identifies the device as intended for use in examining specimens derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or condition.
N/A
Intended Use / Indications for Use
The Sysmex® XS-1000iC is an automated hematology analyzer for in vitro diagnostic use in clinical laboratories and reference laboratories. The XS-1000iC will extend MCV stability to 48 hours.
Product codes (comma separated list FDA assigned to the subject device)
GKZ
Device Description
The Sysmex® XS-1000iC is part of the XS-Series instrument line. It is a multi-parameter hematology analyzer intended to perform tests in anti-coagulated blood. The instrument consists of three principal units: (1) Main Unit which aspirates, dilutes, mixes and analyzes blood samples; (2) Auto Loader that supplies samples to the Main Unit automatically; (3) IPU (Information Processing Unit) which processes data from the Main Unit and provides the operator interface with the system.
The XS-Series instruments provide accurate and precise test results for up to 21 analysis parameters in whole blood. These include: WBC White Blood Cell Count RBC Red Blood Cell Count HGB Hemoglobin HCT Hematocrit MCV Mean Cell Volume MCH Mean Cell Hemoglobin MCHC Mean Cell Hemoglobin Concentration PLT Platelet Count MPV Mean Platelet Volume RDW-SD RBC Distribution Width-SD RDW-CV RBC Distribution Width-CV NEUT%/# Neutrophil Percent and Count LYMPH%/# Lymphocyte Percent and Count MONO%/# Monocyte Percent and Count EO%/# Eosinophil Percent and Count BASO%/# Basophil Percent and Count
The instrument processes approximately 60 samples per hour, depending on the mode used. The XS display various scattergrams, along with data for the reportable parameters. It displays the following analysis results on the IPU screen: WBC 5DIFF, White blood cells/Basophils, RBC pattern data of cell size distribution curves for platelet and analysis parameters. Analysis results and graphics can be printed on any of the available printers or transmitted to a Host computer. Sample abnormalities are indicated by abnormal marks, flags and error messages which appear on the LCD display screen and on the printout. This is an indication that the sample is not within the acceptable range and requires further review and investigation. There are two discrete testing options --- CBC and CBC with Diff. The XS performs analyses using the following methods: Sheath Flow DC Detection Method, Flow Cytometry Methods using a Semiconductor Laser and SLS-hemoglobin method. Blood cells pass through the aperature of the detector surrounded by sheath fluid using the sheath flow method. The principle of flow cytometry is also used. A semiconductor laser beam is emitted to the blood cells passing through the flow cell. The forward scattered light is received by the photodiode, and the lateral scattered light and lateral fluorescent light are received by the photo multiplier tube. This light is converted tinto electrical pulses, thus making it possible to obtain blood cell information. Hemoglobin is measured with the SLS-hemoglobin method using Sodium Lauryl Sulfate, which is an analysis method used in our previous instrumentation.
A modification kit will be installed on a standard XS-1000i instrument where samples >48 hours are analyzed. This modification kit includes software and hardware changes and includes a modified reagent, Cellsheath (C). In this modification, the RBC/PLT dilution process will now be diluted using the Cellsheath (C) reagent after being warmed past 20℃. Software and hardware modifications include changes to the instrument's tubing and modification of the heating block. This only impacts the RBC/PLT dilution step. The WBC and HGB parameters are not impacted. This modification kit was not a change due to recall or corrective action, labeling change, technology or performance change or materials change.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
in clinical laboratories and reference laboratories.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance of the XS-1000iC is the same as the XE-2100DC. Comparison of the XS-1000iC to the XE-2100DC demonstrated substantial equivalence.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 864.5220 Automated differential cell counter.
(a)
Identification. An automated differential cell counter is a device used to identify one or more of the formed elements of the blood. The device may also have the capability to flag, count, or classify immature or abnormal hematopoietic cells of the blood, bone marrow, or other body fluids. These devices may combine an electronic particle counting method, optical method, or a flow cytometric method utilizing monoclonal CD (cluster designation) markers. The device includes accessory CD markers.(b)
Classification. Class II (special controls). The special control for this device is the FDA document entitled “Class II Special Controls Guidance Document: Premarket Notifications for Automated Differential Cell Counters for Immature or Abnormal Blood Cells; Final Guidance for Industry and FDA.”
0
510(k) SUMMARY of the XS-1000iC
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92. The assigned 510(k) number is: КО816 10
| 1. Submitted by: | Sysmex America, Inc.
One Nelson C. White Parkway
Mundelein, IL 60060
Phone: (847) 996-4675; FAX: (847) 996-4655
Contact person: Nina Gamperling
Date prepared: May 30, 2008 | | |
|------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--|--|
| 2. Name of Device: | Trade or proprietary name: Sysmex® XS-1000iC
Common name: Automated Hematology Analyzer.
Classification name:
Sysmex® XS-Series, Automated Hematology, an Automated
Differential Cell Counter (21 CFR 864.5220) is a Class II device.
Related Items:
CELLSHEATH (C)TM (Diluent) Product Code: 81GIF
STROMATOLYSER-4DLTM (Lyse) Product Code: 81GGK
STROMATOLYSER-4DSTM (Stain) Product Code: 81KJK
SULFOLYSER (Lyse) Product Code: 81GGK
XS Calibrator Product Code: 81KSA
e-Check (Control) Product Code: 81JPK
Option: Graphic printer and Bar code Reader | | |
| 3. Predicate Method: | Sysmex® XE-2100DC (K051459-Cleared Sept 23, 2005) | | |
| 4. Device Description: | The Sysmex® XS-1000iC is part of the XS-Series instrument line. It is a
multi-parameter hematology analyzer intended to perform tests in anti-
coagulated blood. The instrument consists of three principal units: (1)
Main Unit which aspirates, dilutes, mixes and analyzes blood samples;
(2) Auto Loader that supplies samples to the Main Unit automatically;
(3) IPU (Information Processing Unit) which processes data from the
Main Unit and provides the operator interface with the system. | | |
| | The XS-Series instruments provide accurate and precise test results for
up to 21 analysis parameters in whole blood. These include:
WBC White Blood Cell Count
RBC Red Blood Cell Count
HGB Hemoglobin
HCT Hematocrit
MCV Mean Cell Volume
MCH Mean Cell Hemoglobin
MCHC Mean Cell Hemoglobin Concentration
PLT Platelet Count
MPV Mean Platelet Volume
RDW-SD RBC Distribution Width-SD
RDW-CV RBC Distribution Width-CV
NEUT%/# Neutrophil Percent and Count
LYMPH%/# Lymphocyte Percent and Count
MONO%/# Monocyte Percent and Count
EO%/# Eosinophil Percent and Count
BASO%/# Basophil Percent and Count | | |
Sysmex XS-1000iC, Automated Hematology Analyzer 510(k) FDA Submission
1
| | The instrument processes approximately 60 samples per hour,
depending on the mode used. The XS display various scattergrams,
along with data for the reportable parameters. It displays the following
analysis results on the IPU screen: WBC 5DIFF, White blood
cells/Basophils, RBC pattern data of cell size distribution curves for
platelet and analysis parameters. Analysis results and graphics can be
printed on any of the available printers or transmitted to a Host
computer. Sample abnormalities are indicated by abnormal marks, flags
and error messages which appear on the LCD display screen and on the
printout. This is an indication that the sample is not within the
acceptable range and requires further review and investigation. There
are two discrete testing options --- CBC and CBC with Diff.
The XS performs analyses using the following methods: Sheath Flow |
|--------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | DC Detection Method, Flow Cytometry Methods using a
Semiconductor Laser and SLS-hemoglobin method. Blood cells pass
through the aperature of the detector surrounded by sheath fluid using
the sheath flow method. The principle of flow cytometry is also used.
A semiconductor laser beam is emitted to the blood cells passing
through the flow cell. The forward scattered light is received by the
photodiode, and the lateral scattered light and lateral fluorescent light
are received by the photo multiplier tube. This light is converted tinto
electrical pulses, thus making it possible to obtain blood cell
information. Hemoglobin is measured with the SLS-hemoglobin
method using Sodium Lauryl Sulfate, which is an analysis method used
in our previous instrumentation. |
| | A modification kit will be installed on a standard XS-1000i instrument
where samples >48 hours are analyzed. This modification kit includes
software and hardware changes and includes a modified reagent,
Cellsheath (C). In this modification, the RBC/PLT dilution process will
now be diluted using the Cellsheath (C) reagent after being warmed past
20℃. Software and hardware modifications include changes to the
instrument's tubing and modification of the heating block. This only
impacts the RBC/PLT dilution step. The WBC and HGB parameters
are not impacted. This modification kit was not a change due to recall
or corrective action, labeling change, technology or performance
change or materials change. |
| 5. Intended Use: | The Sysmex® XS-1000iC is an automated hematology analyzer for in
vitro diagnostic use in clinical laboratories and reference laboratories.
The XS-1000iC will extend MCV stability to 48 hours. |
| 6. Substantial
equivalence-
Similarities and
Differences: | Table 1 shows substantial equivalence of the XS-1000iC to the XS-
2100DC. |
| 7. Conclusion | The XS-1000iC demonstrates substantial equivalence to the XE-
2100DC. |
2
Table 1: Substantial Equivalence—Similarities and Difference to XE-2100DC | |||
---|---|---|---|
Sysmex XE-2100DC | |||
Predicate | Sysmex XS-1000iC | ||
Modification of Predicate | Similarity/ | ||
Difference | |||
Intended Use | The Sysmex® XE-2100DC is | ||
an automated hematology | |||
analyzer for in vitro diagnostic | |||
use in clinical laboratories and | |||
reference laboratories. The | |||
XE-2100DC will extend MCV | |||
stability to 48 hours. | The Sysmex® XS-1000iC is an | ||
automated hematology analyzer | |||
for in vitro diagnostic use in | |||
clinical laboratories and | |||
reference laboratories. The XS- | |||
1000iC will extend MCV | |||
stability to 48 hours. | Both systems have the same | ||
intended use. | |||
Methodology | The XE-2100DC performs | ||
analyses using the following | |||
methods: Sheath Flow DC | |||
Detection Method, and Flow | |||
Cytometry Methods using a | |||
Semiconductor Laser and | |||
SLS-hemoglobin method. | The XS-1000iC performs | ||
analyses using the following | |||
methods: Sheath Flow DC | |||
Detection Method, Flow | |||
Cytometry Methods using a | |||
Semiconductor Laser and SLS- | |||
hemoglobin method. | Both systems use the same | ||
methodology. | |||
Reagents | CELLPACKTM (Diluent) | ||
CELLSHEATH (C)TM (Diluent) | |||
STROMATOLYSER-FBTM (Lyse) | |||
STROMATOLYSER-4DLTM (Lyse) | |||
STROMATOLYSER-4DSTM (Stain) | |||
STROMATOLYSER-NRTM (Diluent) | |||
STROMATOLYSER-NRTM (Stain) | |||
STROMATOLYSER-IMTM (Lyse) | |||
SULFOLYSER (Lyse) | CELLSHEATH (C)TM (Diluent) | ||
STROMATOLYSER-4DLTM (Lyse) | |||
STROMATOLYSER-4DSTM (Stain) | |||
SULFOLYSER (Lyse) | The XE-2100DC and the XS- | ||
1000iC use some of the same | |||
reagents. The XS-1000iC does | |||
not report out all the parameters | |||
that the XE-2100DC does so not | |||
all reagents are used on the XS- | |||
1000iC. | |||
Quality | |||
Control/ | |||
Calibrator | e -Check—3 levels | ||
XE Calibrator (X Cal) | e -Check—3 levels | ||
XE Calibrator (X Cal) | The XE-2100DC and the XS- | ||
1000iC use the same calibrator | |||
and control material | |||
Software/ | |||
Hardware | |||
Differences | A modification kit was | ||
installed on a standard XE- | |||
2100 instrument where | |||
samples >48 hours are | |||
analyzed. This modification | |||
kit includes software and | |||
hardware changes and | |||
includes a modified reagent, | |||
Cellsheath (C). In this | |||
modification, the RBC/PLT | |||
dilution process will now be | |||
diluted using the Cellsheath | |||
(C) reagent after being | |||
warmed past 20°C. Software | |||
and hardware modifications | |||
include changes to the | |||
instrument's tubing and | |||
modification of the heating | |||
block. This only impacts the | |||
RBC/PLT dilution step. The | |||
WBC and HGB parameters | |||
are not impacted. This | |||
modification kit was not a | A modification kit was installed | ||
on a standard XS-1000i | |||
instrument where samples >48 | |||
hours are analyzed. This | |||
modification kit includes | |||
software and hardware changes | |||
and includes a modified reagent, | |||
Cellsheath (C). In this | |||
modification, the RBC/PLT | |||
dilution process will now be | |||
diluted using the Cellsheath (C) | |||
reagent after being warmed past | |||
20°C. Software and hardware | |||
modifications include changes to | |||
the instrument's tubing and | |||
modification of the heating | |||
block. This only impacts the | |||
RBC/PLT dilution step. The | |||
WBC and HGB parameters are | |||
not impacted. This modification | |||
kit was not a change due to | |||
recall or corrective action, | |||
labeling change, technology or | There is no difference in the | ||
modification kit. |
Table 1: Substantial Equivalence-Similarities and Difference to XE-2100DC | ||
---|---|---|
-- | --------------------------------------------------------------------------- | -- |
:
।
3
| | corrective action, labeling
change, technology or
performance change or
materials change. | change. | |
|----------------------|----------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------|
| Specimen
Type | Random whole blood samples | Random whole blood samples. | Both systems use the same
specimen types. |
| Throughput | Approximately 113-150
samples/hour depending on
the mode used. | Approximately 60 samples/hour
depending on the mode used. | There is a difference in the
number of samples/hour. |
| Equivalency
Data: | Performance was established
in XE-2100DC 510(k)
submission (K051459). | Performance of the XS-1000iC
is the same as the XE-2100DC.
Comparison of the XS-1000iC to
the XE-2100DC demonstrated
substantial equivalence. | Performance was substantial
equivalence. |
Sysmex XS-1000iC, Automated Hematology Analyzer 510(k) FDA Submission
· ·
4
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services (HHS). The logo consists of a stylized depiction of an eagle or bird-like figure with three curved lines representing its wings or body. The logo is surrounded by text that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES (USA)" in a circular arrangement. The text is in all caps and is positioned around the perimeter of the logo.
Public Health Service
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
Sysmex America, Inc. C/O Nina Gamperling One Nelson C. White Parkway Mundelein, Illinois 60060
AUG 2 9 2008
Re: K081610
Trade/Device Name: Sysmex Model XS-1000iC Automated Hematology Analyzer Regulation Number: 21 CFR 864.5220 Regulation Name: Automated Differential Hematology Analyzer Regulatory Class: Class II Product Code: GKZ Dated: August 13, 2008 Received: August 15, 2008
Dear Ms. Gamperling:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket
5
Page 2 - Sysmex America, Inc.
notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
Marie Mchen
Maria M. Chan, Ph.D. Acting Division Director Division of Immunology and Hematology Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
6
Indications for Use
510(k) Number (if known): KOS (q / O
Device Name: Sysmex® XS-1000iC, Automated Hematology Analyzer
Indications For Use: The Sysmex® XS-1000iC is an automated hematology analyzer for in vitro diagnostic use in clinical laboratories and reference laboratories. The XS-1000iC will extend MCV stability to 48 hours.
Duphine Bautista
Division/Sign-Off
Office of In Vitro Diagnostic Device Evaluation and Safety
Prescription Use _____________________________________________________________________________________________________________________________________________________________
(Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)